The decision broadens the scope of practice of advanced medical nurses (“PA”), temporarily accepting medical control obligations and allowing them to prescribe safe controlled substances (SDCs) independently. The Palestinian Authority may perform functions and tasks entrusted by the supervisory physician when the service is under the responsibility of the Palestinian Authority and under control. N.J. Rev Stat. 45:9–27.16 The objective of this executive order is to increase the number of health professionals available for the treatment of patients during the COVID-19 emergency who are ready to treat patients and allow NPAs and APAs to be treated independently of physicians during the Covid-19 emergency. Governor Murphy is taking aggressive steps to make the state of New Jersey better prepared if the number of doctors currently active in New Jersey is not enough to treat the growing number of patients with COVID-19. This executive order follows previous steps taken by the state to expand access to telemedicine services, and Rutgers University, which a month earlier concluded 192 students from the New Jersey School of Medicine. These measures allow more health professionals, including NPAs and PAs, to provide essential services during the COVID 19 pandemic, without a large number of the regulatory restrictions imposed on these licensees generally imposed. The College temporarily repeals the requirement for PNs to cooperate with a cooperating physician and removes requirements for medical cooperation and the signing of medical charts, authorization to issue anesthetics for chronic pain treatment or detoxification, and identification of medical services necessary to treat substance use disorders. The decision removes the restrictions and obligations of doctors in monitoring EPAs and removes the requirement for delegation agreements for EPAs.
A PA may prescribe scheduled substances II‑V if approved by the supervising physician. N.J. Rev Stat. 45:9–27.16, N.J. Rev. Stat. 45:9–27.19 Since August 2018, 135 NPs in New Jersey have received a federal exception to treat opioid dependence with products containing buprenorphine. In accordance with their normative authority and with appropriate training or experience, NPNs may receive a federal waiver to distribute products containing buprenorphine as long as the supervising physician is certified, trained or authorized to treat and treat patients with opioid use disorders. N.J.
State Board of Medical Examiners Laws .45:11–49 © Appropriate monitoring is established at the office level between the physician and the AP. N.J. Rev Stat. 45:9–27.18 New Jersey Governor Philip Murphy signed Executive Order 112 on April 1, 2020 and authorized the New Jersey Consumer Affairs Division (DCA) to temporarily reactivate the licenses of recently retired health care professionals and to grant temporary licenses to physicians licensed abroad. The executive order also allows nurses and medical assistants (APNs) and medical assistants (PAs) with temporary licenses in New Jersey to perform services independently without the collaboration or supervision generally required with a physician. Finally, the executive order grants broad civil immunity to health care professionals and institutions that faithfully provide services as part of COVID-19‘s response efforts in New Jersey. An NP must work with a physician to give authorizations for the prescribed authorizations. The NP must consult with the supervisor to prescribe controlled substances and the NP must complete pharmacology training in relation to controlled substances.
NPs of the N.J. State Board of Medical Examiners Laws .45:11–49 © NPs are recognized as primary service providers in state policies. The primary care provider includes the following certified individuals: physicians, medical assistants, nurses whose professional practice includes the provision of primary medicine, including internal medicine, family medicine, geriatric care, paediatric or obstetric care.